Genevation Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Angel

  • Latest Deal Amount
  • $253K

  • Investors
  • 3

Genevation General Information

Description

Developer of an artificial intelligence (AI)-enabled mRNA vaccine platform designed to develop personalized cancer immunotherapies. The company offers artificial intelligence (AI) -driven neoantigen discovery, computational vaccine design, and cell-free manufacturing capabilities, enabling biotechnology companies and healthcare organizations to develop personalized mRNA vaccines for oncology and precision medicine applications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom
+44 07982
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • Stevenage Bioscience Catalyst
  • Gunnels Wood Road
  • Stevenage SG1 2FX
  • England, United Kingdom
+44 07982

Genevation Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genevation Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Angel (individual) 01-Jun-2024 $253K Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-May-2024 Completed Pre-Clinical Trials
2. Seed Round 30-Nov-2023 $248K $248K Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Genevation’s complete valuation and funding history, request access »

Genevation Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary
Ordinary
Ordinary 250,000 $0.000126 $0.51 $0.51 1x $0.51 20%
To view Genevation’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Genevation Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of an artificial intelligence (AI)-enabled mRNA vaccine platform designed to develop personalized cancer immun
Biotechnology
Stevenage, United Kingdom
2 As of 2025

Mainz, Germany
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Genevation Competitors (3)

One of Genevation’s 3 competitors is BioNTech, a Formerly VC-backed company based in Mainz, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioNTech Formerly VC-backed Mainz, Germany
Moderna Formerly VC-backed Cambridge, MA
Pfizer Corporation New York, NY
You’re viewing 3 of 3 competitors. Get the full list »

Genevation Patents

Genevation Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202405562-D0 Cancer vaccine Inactive 19-Apr-2024
WO-2025219529-A1 Cancer vaccine Pending 19-Apr-2024

Genevation Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Genevation Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioIndustry Association Accelerator/Incubator
Oxford Technology Management Venture Capital Minority
Colorintech Accelerator/Incubator
To view Genevation’s complete investors history, request access »

Genevation FAQs

  • When was Genevation founded?

    Genevation was founded in 2022.

  • Where is Genevation headquartered?

    Genevation is headquartered in Stevenage, United Kingdom.

  • What is the size of Genevation?

    Genevation has 2 total employees.

  • What industry is Genevation in?

    Genevation’s primary industry is Biotechnology.

  • Is Genevation a private or public company?

    Genevation is a Private company.

  • What is the current valuation of Genevation?

    The current valuation of Genevation is .

  • What is Genevation’s current revenue?

    The current revenue for Genevation is .

  • How much funding has Genevation raised over time?

    Genevation has raised $501K.

  • Who are Genevation’s investors?

    BioIndustry Association, Oxford Technology Management, and Colorintech have invested in Genevation.

  • Who are Genevation’s competitors?

    BioNTech, Moderna, and Pfizer are competitors of Genevation.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process